Intellia Therapeutics Inc buy Cantor Fitzgerald
Start price
24.06.24
/
50%
€23.43
Target price
24.06.25
€60.53
Performance (%)
-64.98%
End price
25.06.25
€8.21
Summary
This prediction ended on 25.06.25 with a price of €8.21. Massive losses of -64.98% were the result for the BUY prediction by Cantor_Fitzgerald. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 16.279% | 16.279% | 25.733% |
| iShares Core DAX® | -1.933% | 2.239% | 16.921% |
| iShares Nasdaq 100 | -0.972% | 0.226% | 5.003% |
| iShares Nikkei 225® | -2.056% | 5.685% | 19.218% |
| iShares S&P 500 | -1.185% | 0.867% | 2.378% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Cantor_Fitzgerald for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.97
18.06.24
18.06.24
€60.53
18.06.25
18.06.25
-64.30%
19.06.25
19.06.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€21.64
04.06.24
04.06.24
€59.71
04.06.25
04.06.25
-68.59%
05.06.25
05.06.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€34.13
13.09.23
13.09.23
€60.55
13.09.24
13.09.24
-41.20%
14.09.24
14.09.24
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€35.09
29.08.23
29.08.23
€59.70
29.08.24
29.08.24
-42.43%
30.08.24
30.08.24
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€37.03
10.08.23
10.08.23
€58.92
10.08.24
10.08.24
-46.44%
11.08.24
11.08.24

